# A Study to Compare How CHF10196 (Florensocatib) is Absorbed Into the Blood When Given Alone and With a Drug That Reduces Stomach Acid in Healthy Male Participants

> **NCT07683793** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 18 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** CHF10196
- **DRUG:** Pantoprazole

## Key facts

- **NCT ID:** NCT07683793
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-14
- **Primary completion:** 2026-12-09
- **Final completion:** 2026-12-09
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07683793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07683793, "A Study to Compare How CHF10196 (Florensocatib) is Absorbed Into the Blood When Given Alone and With a Drug That Reduces Stomach Acid in Healthy Male Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07683793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*